27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Shares of Vanda Pharmaceuticals (NASDAQ:VNDA) were flat in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share rose 6.25% year over year to $0.17, which beat the estimate of $0.14.
Revenue of $67,899,000 rose by 9.15% year over year, which missed the estimate of $69,750,000.
Outlook
Vanda Pharmaceuticals Sees FY21 Revs $270M-$300M Vs $282.92M
Details Of The Call
Date: Jul 28, 2021
Time: 04:30 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/34ig3ksm
Price Action
Company's 52-week high was at $21.86
Company's 52-week low was at $9.00
Price action over last quarter: Up 11.54%
Company Profile
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include Tradipitant (VLY-686), VTR-297, and VQW-765.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!